Skip to main content
Contact Us
Sign Up
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Carefusion
September 01, 2016
Medtech mergers still the driving force behind jobs changes
March 11, 2016
BD spin-out points to more private equity in medtech
February 01, 2016
Abbott pays $5.8bn to climb the diagnostics rankings
January 12, 2016
Big-cap medtech shares stutter
October 06, 2015
A new leader for the medtech industry thanks to mega M&A
August 05, 2015
Fewer, but bigger: medtech jobs jump thanks to mergers
July 06, 2015
Medtech on course for $100bn in mergers by year-end
January 13, 2015
Mergers fuel big-cap medtech stocks in 2014
November 05, 2014
The next medtech megamerger?
October 14, 2014
Synergy buy shows Steris keeping faith with inversions
October 07, 2014
Medtech worth half a trillion dollars in 2020 – with a new leader in the offing
Load More
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
February 17, 2023
PD(L)anner – February 2023
February 09, 2023
Biopharma and Medtech Review 2022
Editor's Picks
March 13, 2023
Silicon Valley Bank: biopharma’s latest crisis
March 13, 2023
Pfizer rescues biotech
February 28, 2023
Why Pfizer (and others) will be interested in Seagen
March 04, 2023
ACC 2023 – Esperion’s outcomes win looks lacklustre
March 06, 2023
T-cell receptor behemoths consolidate? Not quite
